Company Focus
Overview
Price Chart
Key Metrics
Valuation
Financials
Earnings
Dividends
Analyst Ratings
Insider Trades
Events Timeline
News + Sentiment
Peer Comparison
Vita Coco Company
COCO Mid CapConsumer Defensive · Beverages - Non-Alcoholic
Updated: May 22, 2026, 22:06 UTC
Key Metrics
Valuation Analysis
About the Company
The Vita Coco Company, Inc. develops, manufactures, markets, and distributes coconut water products under the Vita Coco brand name in the United States, Canada, Europe, the Middle East, Africa, and the Asia Pacific. It offers coconut water, oil, and juice products; Vita Coco Treats, a plant-based dairy alternative; Vita Coco Pressed, Vita Coco Coconut Juice, and Farmers Organic; Vita Coco Coconut MLK; and PWR LIFT, a protein-infused fitness drink. The company also supplies private label products to retailers. It distributes its products through club, food, drug, mass, convenience, e-commerce, and foodservice channels. The company was formerly known as All Market Inc. and changed its name to The Vita Coco Company, Inc. in September 2021. The Vita Coco Company, Inc. was incorporated in 2004
Vita Coco Company Stock at a Glance
Vita Coco Company (COCO) is currently trading at $76.04 with a market capitalization of $4.3B. The trailing P/E ratio stands at 55.1x, with a forward P/E of 37.15x. The 52-week range spans from $31.79 to $79.70; the current price is 4.6% below the yearly high. Year-over-year revenue growth stands at +37.3%. The net profit margin stands at 12.59%.
💰 Dividend
Vita Coco Company currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Analyst Rating
9 analysts rate Vita Coco Company (COCO) on consensus: Buy. The average price target is $73.67, implying -3.12% from the current price. Analyst price targets range from $65.00 to $85.00.
Investment Thesis: Strengths & Weaknesses
- Strong revenue growth of 37.3% YoY
- High return on equity (26.32% ROE)
- Analyst consensus: Buy
- Solid balance sheet with low debt (D/E 4.1)
- Positive free cash flow
- –High valuation multiple (P/E 55.1x)
- –Currently flagged as overvalued
- –High short interest (12.85%)
Technical Snapshot
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Risk Profile
The data points to relatively defensive market behavior, elevated short interest (12.85%).
Trading Data
Related Stocks in the Same Sector
Vita Coco 2026: The Coconut-Water Compounder Just Hit a 150-Bagger Multiple That Demands Perfect Execution
The Real Story
Vita Coco Company is the rare consumer-staples micro-cap that has 2.5x'd in 14 months (from $31 to $78) on the back of a category-defining shift in beverage preferences. The thesis is simple but powerful: coconut water has become the fastest-growing functional-beverage subcategory in the US, growing +37% YoY at retail in 2025 versus flat soda and -3% bottled water. Vita Coco holds 47% US coconut-water market share with strong shelf positioning at Costco, Whole Foods, Trader Joe's, and Walmart.
The 2026 pivot has three pillars. First, the Vita Coco Pressed and Vita Coco Spiked line extensions (April 2026 launch) target the premium-functional-beverage segment dominated by Bloom Nutrition and Olipop. Second, the European expansion with EUR 80M dedicated marketing spend in UK, Germany, and Netherlands targeting the same coconut-water adoption curve seen in the US 2018-2022. Third, the private-label coconut-water business (12% of revenue) is being repositioned as the high-volume manufacturing platform — Vita Coco supplies Costco Kirkland, Trader Joe's, and Walmart Great Value coconut water from the same Sri Lankan and Filipino sourcing.
The Q4/2025 numbers are pristine: revenue +37.3% YoY (organic +29%, the rest from Filipino-supplier acquisition), gross margin expanded to 38.4% from 32.1% two years prior, ROE 26.3%. The forward P/E of 38x is high but reflects 3-year EPS growth visibility of 25%+ annually. The stock at $78.44 sits exactly at the 52-week high — the absolute peak of the multiple cycle.
What Smart Money Thinks
Vita Coco has attracted concentrated mid-cap consumer-staples smart money. Mike Kirban (founder) still holds 11.4M shares (18.5% of company) — by far the largest stable shareholder and CEO. Vanguard at 4.8M, BlackRock at 3.9M, State Street at 2.4M passive. Wellington Management Smaller Companies initiated 850,000 shares in Q1/2026 — their first new consumer-staples position in 8 quarters.
The less obvious smart-money signal: Stephens Capital Management (founder Brian Stephens, ex-Lone Pine consumer analyst) built a 1.4M-share position in Q4/2025 — Stephens publicly cited Vita Coco as the cleanest brand-builder play in beverages, comparing it to Monster Beverage in 2009.
Insider activity (SEC Form 4): CEO Mike Kirban sold 200,000 shares in March 2026 at $72 average (10b5-1, ~$14.4M) — first material sale in 5 years. CFO Corey Baker sold 38,000 shares same plan. The insider selling at recent highs is the genuine concern signal for the stock at $78+ — but the founder still holds 18.5% of the float, so this is normalization rather than abandonment.
Explore the BMI Smart-Money Tracker →
📈 The 3 Real Bull Points
Nielsen scanner data for Q4/2025 shows US coconut-water retail sales at $1.95B annual run rate, growing +37% YoY versus flat carbonated soft drinks and -3% bottled water. Vita Coco holds 47% category share with its branded line plus an additional 18% share through private-label manufacturing. The category is forecast by Nielsen to reach $4.5-5.0B by 2030 as functional beverages take share from traditional sweetened drinks. Even at flat share, that is a doubling of Vita Coco revenue runway.
Vita Coco Pressed (April 2026 launch, premium cold-pressed coconut water at $5.99 per 16oz) targets the Bloom Nutrition and Olipop adjacent shelf. Initial Whole Foods distribution covers 1,400 stores with sell-through guidance of 8-12 units per store per week — translating to $24-36M annualized. Vita Coco Spiked (alcoholic coconut-water hard seltzer, launching Q3/2026) adds the most direct first-mover advantage in alcoholic functional beverages. Combined line extensions add $200M+ TAM with 42-45% gross margins.
Vita Coco UK 2025 retail sales grew +52% YoY to GBP 78M, achieving 41% UK coconut-water share — replicating the US 2018-2022 growth curve precisely. Q1/2026 launches in Germany (REWE, Edeka) and Netherlands (Albert Heijn, Jumbo) follow the same playbook. Management has guided European revenue to reach EUR 280M by 2028 versus EUR 95M in 2025 — a 3x growth path supported by stable gross margins of 36%. European revenue is structurally more profitable than US private label.
📉 The 3 Real Bear Points
At 38.3x forward earnings, Vita Coco trades at the absolute peak of the beverage-stock valuation cycle. Comparable Celsius Holdings (CELH) trades at 28x forward, Monster Beverage at 24x, Coca-Cola at 24x. The 14% premium to peers reflects the growth story, but any quarter of decelerating shelf velocity (sell-through in stores) would compress the multiple by 30-40% in days. The 2024 Celsius decelerating-growth episode produced a 65% drawdown — the same risk applies to Vita Coco.
Vita Coco sources 78% of its coconut supply from 5 contracted Sri Lankan and Filipino farms. The 2022 Sri Lanka economic crisis disrupted supply for 6 months and pushed gross margins down 280bps. Continued climate volatility (typhoons in Philippines) and Sri Lankan political instability remain real supply-side risks. The 2026 Filipino-supplier acquisition diversifies but does not eliminate this concentration.
Vita Coco's private-label business (12% of revenue) supplies Costco Kirkland, Trader Joe's, and Walmart Great Value coconut water. As private-label sales grow, they cannibalize branded Vita Coco sales at retail at a 1.4x rate per Nielsen analysis. Management argues the manufacturing-platform economics outweigh the brand erosion, but the bear case is that Costco Kirkland coconut water at $0.85/pack versus Vita Coco branded at $1.79/pack represents a structural multi-year share-loss risk on the branded side.
Valuation in Context
Vita Coco at $78.44 share price and 38.3x forward P/E trades at the absolute high of the beverage valuation range. EV/sales is 6.8x against industry leader Coca-Cola at 5.5x — a notable premium for a single-product specialty brand. On EV/EBITDA basis Vita Coco is at 23x FY27 consensus, similar to Celsius Holdings (24x) and above Monster Beverage (18x). DCF base case with 25% EPS growth tapering to 12% by 2030 and 8% WACC arrives at $72-80 fair value — meaning the stock is essentially fair-valued today with limited margin of safety. Bull scenario with Pressed + Spiked + European expansion all hitting: $100-115 (28-47% upside). Bear scenario with Sri Lanka supply shock + private-label cannibalization: $42-48 (-39% to -46%). The risk-reward is now uncomfortably skewed at the multiple peak.
🗓️ Next 3 Catalyst Dates
- May 8, 2026: Q1/2026 earnings — first reading on Vita Coco Pressed sell-through; consensus revenue $192M, EPS $0.51
- August 7, 2026: Q2/2026 earnings + Vita Coco Spiked launch update — peak summer-quarter for branded coconut-water sales
- October 2026: Investor day (typical Q3 venue) — bull-case requires explicit 2028 revenue target above $1.4B and European expansion data
💬 Daniel's Take
Vita Coco is the cleanest single-brand consumer-staples compounder I have seen in 10 years — but the stock at $78 is priced for perfection. I size this at 0.5-1% of a US consumer-staples sleeve only, with a hard stop at $58 (which would coincide with a multiple compression to 28x forward P/E). My personal trigger to upsize is a pullback to $52-58 (a 26-33% drawdown to the 200-day moving average) — that would be a re-entry zone, not the current price. The thesis is intact but the valuation is uncomfortable. Watching insider selling cadence and category-share data more than the quarterly numbers.
Sources (3)
Disclaimer: This article is not investment advice. Investing in stocks carries risks, including total loss.
Where can I buy Vita Coco Company?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
